0001193125-12-146316.txt : 20120402 0001193125-12-146316.hdr.sgml : 20120402 20120402171203 ACCESSION NUMBER: 0001193125-12-146316 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120402 DATE AS OF CHANGE: 20120402 EFFECTIVENESS DATE: 20120402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PONIARD PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000755806 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911261311 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-16614 FILM NUMBER: 12734202 BUSINESS ADDRESS: STREET 1: 750 BATTERY STREET STREET 2: SUITE 330 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 2062862501 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 530 CITY: SEATTLE STATE: WA ZIP: 98119-4114 FORMER COMPANY: FORMER CONFORMED NAME: NEORX CORP DATE OF NAME CHANGE: 19920703 15-12G 1 d326680d1512g.htm FORM 15 Form 15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 

     0-16614            

 

Poniard Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

 

300 Elliott Avenue West, Suite 530, Seattle, WA 98119, (206) 281-7001
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, $0.02 par value,

$2.4375 Convertible Exchangeable Preferred Stock, Series 1, $0.02 par value

(Title of each class of securities covered by this Form)

 

(Titles of all other classes of securities for which a duty to file reports under section 12(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   þ
Rule 12g-4(a)(2)   ¨
Rule 12h-3(b)(1)(i)   þ
Rule 12h-3(b)(1)(ii)   ¨
Rule 15d-6   ¨

Approximate number of holders of record as of the certification or notice date:         104                

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

     
Date:   April 2, 2010     By:   /s/ Michael K. Jackson
        Michael K. Jackson
        Interim Chief Financial Officer